{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:24:55Z","timestamp":1787246695865,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13555-026-01820-z","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:01:23Z","timestamp":1782277283000},"page":"4191-4204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study"],"prefix":"10.1007","volume":"16","author":[{"given":"David","family":"Saceda-Corralo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Imbernon-Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jim\u00e9nez-Cauhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pindado-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Balaguera-Orjuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Burgos-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Guillem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-0402","authenticated-orcid":false,"given":"Roc\u00edo","family":"Gil-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"1820_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/ijd.13204","volume":"55","author":"A Rebora","year":"2016","unstructured":"Rebora A. Trichodynia: a review of the literature. Int J Dermatol. 2016;55:382\u20134.","journal-title":"Int J Dermatol"},{"issue":"6","key":"1820_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000533795","volume":"9","author":"EN Souza","year":"2023","unstructured":"Souza EN, Anzai A, Costa Fechine CO, Sakai Valente NY, Romiti R. Sensitive scalp and trichodynia: epidemiology, etiopathogenesis, diagnosis, and management. Skin Appendage Disord. 2023;9(6):407\u201315.","journal-title":"Skin Appendage Disord"},{"issue":"24","key":"1820_CR3","first-page":"00717","volume":"S0001\u20137310","author":"G Rodriguez-Tamez","year":"2024","unstructured":"Rodriguez-Tamez G, Imbernon-Moya A, Saceda-Corralo D, et\u00a0al. Dermatology update on the challenging trichodynia. Actas Dermosifiliogr. 2024;S0001\u20137310(24):00717\u20138.","journal-title":"Actas Dermosifiliogr"},{"key":"1820_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0974-7753.96900","volume":"4","author":"H Kang","year":"2012","unstructured":"Kang H, Jeong K, Dam Jung H, Hyun Cho S, Min Park Y, Eun Kim J. Increased expression of nerve growth factor and neurokinin-1 alarm the hair loss in female with trichodynia. Int J Trichol. 2012;4:131\u201352.","journal-title":"Int J Trichol"},{"issue":"16","key":"1820_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164898","volume":"13","author":"K Ko\u0142cz","year":"2024","unstructured":"Ko\u0142cz K, Krawczyk-Wo\u0142oszyn K, Reich A, \u017bychowska M. Pruritus in lichen planopilaris and frontal fibrosing alopecia-clinical characteristics and dermoscopic correlations. J Clin Med. 2024;13(16):4898.","journal-title":"J Clin Med"},{"issue":"12","key":"1820_CR6","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1111\/jdv.19381","volume":"37","author":"R Singh","year":"2023","unstructured":"Singh R, Wilborn D, Lintzeri DA, Blume-Peytavi U. Health-related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): a systematic review. J Eur Acad Dermatol Venereol. 2023;37(12):2462\u201373.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1820_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamadermatol.2017.6330","volume":"154","author":"D Saceda-Corralo","year":"2018","unstructured":"Saceda-Corralo D, Pindado-Ortega C, Moreno-Arrones \u00d3M, Fern\u00e1ndez-Gonz\u00e1lez P, Rodrigues-Barata AR, Ja\u00e9n-Olasolo P, et\u00a0al. Health-related quality of life in patients with frontal fibrosing alope-cia. JAMA Dermatol. 2018;154(4):479\u201380.","journal-title":"JAMA Dermatol"},{"key":"1820_CR8","volume":"16","author":"FA Alhomida","year":"2024","unstructured":"Alhomida FA, Alkhezzi S, Alshammari R, Alasmari BS, AlDosari DA, AlNasser M, et\u00a0al. Successful treatment of refractory trichodynia with Onabotulinumtoxin-A. Cureus. 2024;16:e57009.","journal-title":"Cureus"},{"issue":"3","key":"1820_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/pm\/pnaa113","volume":"22","author":"M Trimboli","year":"2021","unstructured":"Trimboli M, Troisi L. Refractory trichodynia treated using Onabotulinumtoxin-A. Pain Med. 2021;22(3):759\u201360.","journal-title":"Pain Med"},{"issue":"3","key":"1820_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jaad.2009.08.054","volume":"62","author":"C Chiang","year":"2010","unstructured":"Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62(3):387\u201392.","journal-title":"J Am Acad Dermatol"},{"key":"1820_CR11","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2105141","volume":"21","author":"L Raciti","year":"2022","unstructured":"Raciti L, Raciti G, Militi D, Casella C, Calabr\u00f2 RS. Chronic migraine: a narrative review on the use of botulinum toxin with clinical indications and future directions. J Integr Neurosci. 2022;21:141.","journal-title":"J Integr Neurosci"},{"issue":"4","key":"1820_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/toxins17040163","volume":"17","author":"SM Perez","year":"2025","unstructured":"Perez SM, AlSalman SA, Nguyen B, Tosti A. Botulinum toxin in the treatment of hair and scalp disorders: current evidence and clinical applications. Toxins. 2025;17(4):163.","journal-title":"Toxins"},{"key":"1820_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"SK Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, et\u00a0al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30:793\u2013803.","journal-title":"Cephalalgia"},{"key":"1820_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"HC Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Silberstein SD, et\u00a0al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804\u201314.","journal-title":"Cephalalgia"},{"key":"1820_CR15","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.3390\/toxins7093818","volume":"7","author":"S Luvisetto","year":"2015","unstructured":"Luvisetto S, Gazerani P, Cianchetti C, Pavone F. Botulinum toxin type A as a therapeutic agent against headache and related disorders. Toxins (Basel). 2015;7:3818\u201344.","journal-title":"Toxins (Basel)"},{"issue":"8","key":"1820_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.nrl.2017.09.003","volume":"35","author":"S Santos-Lasaosa","year":"2020","unstructured":"Santos-Lasaosa S, Cuadrado ML, Gago-Veiga AB, et\u00a0al. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine. Neurologia. 2020;35(8):568\u201378.","journal-title":"Neurologia"},{"issue":"6","key":"1820_CR17","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2353\/ajpath.2007.061206","volume":"171","author":"EM Peters","year":"2007","unstructured":"Peters EM, Liotiri S, Bod\u00f3 E, et\u00a0al. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol. 2007;171(6):1872\u201386.","journal-title":"Am J Pathol"},{"issue":"4","key":"1820_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000444758","volume":"1","author":"MJ Harries","year":"2016","unstructured":"Harries MJ, Wong S, Farrant P. Frontal fibrosing alopecia and increased scalp sweating: Is neurogenic inflammation the common link? Skin Appendage Disord. 2016;1(4):179\u201384.","journal-title":"Skin Appendage Disord"},{"issue":"3","key":"1820_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/exd.13835","volume":"29","author":"I Doche","year":"2020","unstructured":"Doche I, Wilcox GL, Ericson M, et\u00a0al. Evidence for neurogenic inflammation in lichen planopilaris and frontal fibrosing alopecia pathogenic mechanism. Exp Dermatol. 2020;29(3):282\u20135.","journal-title":"Exp Dermatol"},{"key":"1820_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/JCAS.JCAS_197_20","volume":"15","author":"K Phan","year":"2022","unstructured":"Phan K, Lin MJ. Botulinum toxin for scalp dysesthesia. J Cutan Aesthet Surg. 2022;15:95\u20136. https:\/\/doi.org\/10.4103\/JCAS.JCAS_197_20.","journal-title":"J Cutan Aesthet Surg"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01820-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01820-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01820-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:29:54Z","timestamp":1787243394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01820-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01820-z","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"David Saceda-Corralo is an Editorial Board member of Dermatology and Therapy. David Saceda-Corralo was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sergio Va\u00f1\u00f3-Galv\u00e1n, Adri\u00e1n Imbernon-Moya, Juan Jim\u00e9nez-Cauhe, Cristina Pindado-Ortega, Valentina Balaguera-Orjuela, Patricia Burgos-Blasco, Amparo Guillem and Roc\u00edo Gil-Redondo have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local IRB (Institutional Review Board\u2014Hospital Ram\u00f3n y Cajal) approved this study, approval number 193\/25. The study was conducted in accordance with the principles of the Declaration of Helsinki of 1964 and its later amendments. Owing to the retrospective nature of the study, the requirement for written informed consent was waived by the Institutional Review Board of Hospital Ram\u00f3n y Cajal.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}